Medicine pills on a manufacturing conveyor belt

UK medicines manufacturing to benefit from £20m funding boost

Prime Minister Boris Johnson has announced a new £20m fund aimed at expanding medicines manufacturing capabilities within the UK, strengthening the country’s ability to respond to future pandemics.

The Government’s new capital investment fund, the Medicines and Diagnostic Manufacturing Transformation Fund, will open up investment opportunities for medicines manufacturers in England, Scotland and Wales – with the intended goal of improving domestic medicine supply chains and created thousands of highly skilled jobs in the process.

It is also expected the new funding boost will help put UK companies ahead of global competitors in advanced medicines manufacturing, while also helping them to respond to future healthcare needs and bolster the UK’s overall health resiliency.

Prime Minister Boris Johnson said: “This new £20m fund will significantly increase the capacity and resilience of our medicines and diagnostics manufacturing supply chains and equip us to fight future health crises.

“Throughout the pandemic we have seen a coming together of British scientific industry and innovation and this new fund will enhance the UK’s manufacturing capabilities even further.”

Business Secretary Alok Sharma added: “The positive and timely response of our medicines manufacturers to the pandemic has been remarkable, but we want to ensure that the UK’s supply chains are even more resilient in the future.

“There are huge opportunities for innovation in medicines and diagnostics, and this new fund will put the UK head and shoulders above others, boosting the UK’s capabilities and generating significant economic opportunities across the country.”

Covid-19 has demonstrated the importance of a strong domestic medicines and manufacturing industry.

This new fund has been established to grow and strengthen the UK’s capabilities by encouraging companies to develop new technologies, build new factories and harness new advances in the field, including bioprocessing, data and using greener manufacturing processes.

With two-thirds of life science manufacturing jobs already based outside London and the South East, the fund will also open up economic opportunities in different parts of the UK, creating thousands of new, highly-skilled manufacturing jobs as well as safeguarding existing roles.

The multi-year fund is set to have an initial pot of £20m, available from next year, as part of the 2021-22 Spending Review, as announced by the Chancellor on November 25, 2020.

Eligible manufacturing companies can bid for the fund to help with their capital costs.

More information will be made available over the coming months, ahead of the fund launching mid-next year. The fund will be run through a competitive process overseen by the Department for Business, Energy and Industrial Strategy.

NHE Sept/Oct 21

NHE Sept/Oct 21

Improving care for long-term conditions

Join us in our September/October edition of National Health Executive, as we explore a range of topics impacting and improving the care that we can deliver to patients, the facilities within which we deliver them, and the opportunities in the digital space to accent and evolve our care capabilities

Videos...

View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Digital Healthcare

The integration of new technology, such as using virtual outpatient appointments instead of face-to-face reviews of patients in the hospital. Adapting the ways in which our NHS workers serve people has been critical in continuing to provide high-quality treatment, a positive patient experience and preventing Covid-19 transmission during the pandemic. Our healthcare sector has the potential to transform the way we continue to provide essential services while also improving patient care. But how easy is the integration of these innovations into routine NHS practice?

On the 28th of October, at the NHE365 Virtual Hospitals & Technology Enabled Care online event, we will be discussing patient flow and experience, reducing waiting times, reducing the patient backlog and increasing technology adoption. Will you be attending? 

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all